SCR Pharmatop's IV Paracetamol Patent Gets Revoked by the IPO

in pharmapatent •  3 years ago 

In a landmark decision, the Indian Patent Office has decided in favor of Venus Remedies with regards to a matter concerning the IV Paracetamol patent. Venus Remedies had challenged SCR Pharmatop’s patent citing that the patent did not comprise of any inventive step. Read more: https://bit.ly/3DIyIGy

Indian-Patent-Office-revokes-SCR-Pharmatop’s-IV-paracetamol-patent-Decides-in-favour-of-Venus-Remedies.jpg

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!